Ophthalmologists point to growing evidence that the GLP-1 class of drugs may be linked to an initial worsening of diabetic retinopathy and, in rare cases, non-arteritic ischemic optic neuropathy
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.






